OBJECTIVE: Brain arteriovenous malformations (AVM) have high matrix metalloproteinase-9, interleukin-6, and myeloperoxidase (MPO) expression, and polymorphic variations in inflammatory genes are associated with an increased risk of hemorrhage. In this study, we characterized the presence of inflammatory cells in AVM lesional tissue specimens. METHODS: Immunohistochemistry was used to identify and localize neutrophils (MPO as marker), macrophages/microglia (CD68 as marker), T lymphocytes (CD3 as marker), and B lymphocytes (CD20 as marker). Endothelial cell (EC) marker CD31 was used as an index to assess vascular mass (EC mass). Surgical specimens from 20 unruptured, nonembolized AVMs were examined; seven cortical samples from temporal lobectomy were used as controls. Positive signals for inflammatory cell markers were counted and analyzed by normalizing to the area of the tissue section and the amount of endothelial cells (cells/mm/EC mass pixels). Levels of MPO and matrix metalloproteinase 9 were determined by enzyme-linked immunosorbent assay. RESULTS: Neutrophils and macrophages are all frequently identified in the vascular wall of AVM tissue. In contrast, T and B lymphocytes are rarely observed in AVM tissue. AVM tissue displayed more neutrophil and macrophage/microglia markers than epilepsy control tissue (MPO: 434 +/- 333 versus 5 +/- 4, P = 0.0001; CD68: 454 +/- 404 versus 4 +/- 2, P = 0.0001; cells/mm/EC mass pixels). In ex vivo studies, neutrophil quantity, MPO, and matrix metalloproteinase-9 levels were all colinear (R = 0.98-0.99). CONCLUSION: Our study demonstrates that inflammatory cells are present in AVM tissue. Taken together with previous genetic and cytokine studies, these data are consistent with a novel view that inflammation is associated with AVM disease progression and rupture.
OBJECTIVE:Brain arteriovenous malformations (AVM) have high matrix metalloproteinase-9, interleukin-6, and myeloperoxidase (MPO) expression, and polymorphic variations in inflammatory genes are associated with an increased risk of hemorrhage. In this study, we characterized the presence of inflammatory cells in AVM lesional tissue specimens. METHODS: Immunohistochemistry was used to identify and localize neutrophils (MPO as marker), macrophages/microglia (CD68 as marker), T lymphocytes (CD3 as marker), and B lymphocytes (CD20 as marker). Endothelial cell (EC) marker CD31 was used as an index to assess vascular mass (EC mass). Surgical specimens from 20 unruptured, nonembolized AVMs were examined; seven cortical samples from temporal lobectomy were used as controls. Positive signals for inflammatory cell markers were counted and analyzed by normalizing to the area of the tissue section and the amount of endothelial cells (cells/mm/EC mass pixels). Levels of MPO and matrix metalloproteinase 9 were determined by enzyme-linked immunosorbent assay. RESULTS: Neutrophils and macrophages are all frequently identified in the vascular wall of AVM tissue. In contrast, T and B lymphocytes are rarely observed in AVM tissue. AVM tissue displayed more neutrophil and macrophage/microglia markers than epilepsy control tissue (MPO: 434 +/- 333 versus 5 +/- 4, P = 0.0001; CD68: 454 +/- 404 versus 4 +/- 2, P = 0.0001; cells/mm/EC mass pixels). In ex vivo studies, neutrophil quantity, MPO, and matrix metalloproteinase-9 levels were all colinear (R = 0.98-0.99). CONCLUSION: Our study demonstrates that inflammatory cells are present in AVM tissue. Taken together with previous genetic and cytokine studies, these data are consistent with a novel view that inflammation is associated with AVM disease progression and rupture.
Authors: Achal S Achrol; Ludmila Pawlikowska; Charles E McCulloch; K Y Trudy Poon; Connie Ha; Jonathan G Zaroff; S Claiborne Johnston; Chanhung Lee; Michael T Lawton; Stephen Sidney; Douglas A Marchuk; Pui-Yan Kwok; William L Young Journal: Stroke Date: 2005-12-01 Impact factor: 7.914
Authors: Yongmei Chen; Yongfeng Fan; K Y Trudy Poon; Achal S Achrol; Michael T Lawton; Yiqian Zhu; Charles E McCulloch; Tomoki Hashimoto; Chanhung Lee; Nicholas M Barbaro; Andrew W Bollen; Guo-Yuan Yang; William L Young Journal: Front Biosci Date: 2006-09-01
Authors: Yongmei Chen; Ludmila Pawlikowska; Jianhua S Yao; Fanxia Shen; Wenwu Zhai; Achal S Achrol; Michael T Lawton; Pui-Yan Kwok; Guo-Yuan Yang; William L Young Journal: Ann Neurol Date: 2006-01 Impact factor: 10.422
Authors: Emiri Tejima; Bing-Qiao Zhao; Kiyoshi Tsuji; Anna Rosell; Klaus van Leyen; R Gilberto Gonzalez; Joan Montaner; Xiaoying Wang; Eng H Lo Journal: J Cereb Blood Flow Metab Date: 2006-06-21 Impact factor: 6.200
Authors: Tomoki Hashimoto; Yongqin Wu; Michael T Lawton; Guo-Yuan Yang; Nicholas M Barbaro; William L Young Journal: Neurosurgery Date: 2005-05 Impact factor: 4.654
Authors: Yi Guo; Tara Saunders; Hua Su; Helen Kim; Deniz Akkoc; David A Saloner; Steven W Hetts; Christopher Hess; Michael T Lawton; Andrew W Bollen; Tony Pourmohamad; Charles E McCulloch; Tarik Tihan; William L Young Journal: Stroke Date: 2012-02-02 Impact factor: 7.914
Authors: Yi Guo; Tarik Tihan; Helen Kim; Christopher Hess; Michael T Lawton; William L Young; Yuanli Zhao; Hua Su Journal: Neuroimmunol Neuroinflamm Date: 2014
Authors: Wanqiu Chen; Yi Guo; Espen J Walker; Fanxia Shen; Kristine Jun; S Paul Oh; Vincent Degos; Michael T Lawton; Tarik Tihan; Dimitrios Davalos; Katerina Akassoglou; Jeffrey Nelson; John Pile-Spellman; Hua Su; William L Young Journal: Arterioscler Thromb Vasc Biol Date: 2012-12-13 Impact factor: 8.311
Authors: Qi Hao; Yiqian Zhu; Hua Su; Fanxia Shen; Guo-Yuan Yang; Helen Kim; William L Young Journal: Transl Stroke Res Date: 2010-09-01 Impact factor: 6.829